Rosamultin attenuates cerebral ischemia/reperfusion injury by inhibiting autophagy via the PI3K/Akt/mTOR pathway
Authors:
Open Access
- 8 April 2025
- journal article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 158 (3) , 182-192
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- HIV protease inhibitor attenuated astrocyte autophagy involvement in inflammation via p38 MAPK pathwayAntiviral Research, 2022
- Calenduloside E alleviates cerebral ischemia/reperfusion injury by preserving mitochondrial functionJournal of Molecular Histology, 2022
- Rosamultin from Potentilla anserine L. exhibits nephroprotection and antioxidant activity by regulating the reactive oxygen species/C/EBP homologous protein signaling pathwayPhytotherapy Research, 2021
- Improvement of cerebral ischemia/reperfusion injury by daucosterol palmitate-induced neuronal apoptosis inhibition via PI3K/Akt/mTOR signaling pathwayMetabolic Brain Disease, 2020
- Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cellsBiomedicine & Pharmacotherapy, 2018
- Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patientsCancer Treatment Reviews, 2017
- Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategiesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2016
- cPKCγ-Modulated Autophagy in Neurons Alleviates Ischemic Injury in Brain of Mice with Ischemic Stroke Through Akt-mTOR PathwayTranslational Stroke Research, 2016
- Autophagy: Renovation of Cells and TissuesCell, 2011
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010